Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PHKA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DGUOK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEL1L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COPB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALG8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PLEKHB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CREBL2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF148 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NRP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FUT3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCDC90B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RIOK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLRC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
C6orf62 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EBAG9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POC1B-GALNT4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAM188A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AREL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BCHE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KDM2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on